Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies
出版年份 2023 全文链接
标题
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies
作者
关键词
-
出版物
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-16
DOI
10.1007/s11154-023-09843-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Circulating microRNAs associated with non-alcoholic fatty liver disease
- (2023) Amila Iriskic Atic et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Fecal microbiota transplantation from young mice rejuvenates aged hematopoietic stem cells by suppressing inflammation
- (2023) Xiangjun Zeng et al. BLOOD
- Gut microbiota therapy for nonalcoholic fatty liver disease: Evidence from randomized clinical trials
- (2023) Ting-Rui Han et al. Frontiers in Microbiology
- Gut microbiota induced epigenetic modifications in the non‐alcoholic fatty liver disease pathogenesis
- (2023) Ruiqi Tang et al. ENGINEERING IN LIFE SCIENCES
- Akkermansia muciniphila as a Next-Generation Probiotic in Modulating Human Metabolic Homeostasis and Disease Progression: A Role Mediated by Gut–Liver–Brain Axes?
- (2023) Huafeng Jian et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
- (2023) Anna Gudan et al. Nutrients
- Associations of physical activity domains and muscle strength exercise with non-alcoholic fatty liver disease: a nation-wide cohort study
- (2023) Yewan Park et al. Scientific Reports
- Research Progress of Fecal Microbiota Transplantation in Liver Diseases
- (2023) Yuanyuan Zhao et al. Journal of Clinical Medicine
- The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease
- (2023) Nurainina Ayob et al. Biomedicines
- Gut microbiota in patients with obesity and metabolic disorders — a systematic review
- (2022) Zhilu XU et al. Genes and Nutrition
- The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease
- (2022) Roberta Forlano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrity of the Intestinal Barrier: The Involvement of Epithelial Cells and Microbiota—A Mutual Relationship
- (2022) Małgorzata Gieryńska et al. Animals
- Dysbiotic Gut Bacteria in Obesity: An Overview of the Metabolic Mechanisms and Therapeutic Perspectives of Next-Generation Probiotics
- (2022) Jonathan Breton et al. Microorganisms
- PPAR-Targeted Therapies in the Treatment of Non-Alcoholic Fatty Liver Disease in Diabetic Patients
- (2022) Naomi F. Lange et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Obesity and gut–microbiota–brain axis: A narrative review
- (2022) Arezoo Asadi et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- The intestinal and biliary microbiome in autoimmune liver disease—current evidence and concepts
- (2022) Timur Liwinski et al. Seminars in Immunopathology
- Bile acids and their receptors: modulators and therapeutic targets in liver inflammation
- (2022) Anna Bertolini et al. Seminars in Immunopathology
- The Microbiome and Gut Endocannabinoid System in the Regulation of Stress Responses and Metabolism
- (2022) Raj Kamal Srivastava et al. Frontiers in Cellular Neuroscience
- Bifidobacterium animalis ssp. lactis MG741 Reduces Body Weight and Ameliorates Nonalcoholic Fatty Liver Disease via Improving the Gut Permeability and Amelioration of Inflammatory Cytokines
- (2022) Moon Ho Do et al. Nutrients
- Alleviation of Hepatic Steatosis: Dithizone-Related Gut Microbiome Restoration During Paneth Cell Dysfunction
- (2022) Saisai Zhang et al. Frontiers in Microbiology
- Elucidating the role of the gut microbiota in the physiological effects of dietary fiber
- (2022) Edward C. Deehan et al. Microbiome
- Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options
- (2022) Tomas Hrncir Microorganisms
- Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease
- (2022) Youn Huh et al. Journal of Obesity & Metabolic Syndrome
- Gut Microbiota—A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic Review
- (2022) Roberta Forlano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review
- (2022) Rodrigo Zamignan Carpi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Current treatment of non‐alcoholic fatty liver disease
- (2022) Rafael Paternostro et al. JOURNAL OF INTERNAL MEDICINE
- Fecal microbiota transplantation in the metabolic diseases: Current status and perspectives
- (2022) Lie Zheng et al. WORLD JOURNAL OF GASTROENTEROLOGY
- A potential link between plasma short‑chain fatty acids, TNF‑α level and disease progression in non‑alcoholic fatty liver disease: A retrospective study
- (2022) Jing Xiong et al. Experimental and Therapeutic Medicine
- Specific Strains of Faecalibacterium prausnitzii Ameliorate Nonalcoholic Fatty Liver Disease in Mice in Association with Gut Microbiota Regulation
- (2022) Wenbing Hu et al. Nutrients
- Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
- (2022) Lanfeng Xue et al. Frontiers in Cellular and Infection Microbiology
- Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota
- (2022) Huong Thi Nguyen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Probiotics suppress nonalcoholic steatohepatitis and carcinogenesis progression in hepatocyte-specific PTEN knockout mice
- (2022) Naoshi Arai et al. Scientific Reports
- Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality
- (2022) Yi Xia et al. Frontiers in Microbiology
- Host-microbiome interactions: Gut-Liver axis and its connection with other organs
- (2022) Swadha Anand et al. npj Biofilms and Microbiomes
- Current Trends and Challenges of Fecal Microbiota Transplantation—An Easy Method That Works for All?
- (2022) Cátia Almeida et al. Biomedicines
- Performance of Restricted Mean Survival Time Based Methods and Traditional Survival Methods: An Application in an Oncological Data
- (2022) Qiao Huang et al. Computational and Mathematical Methods in Medicine
- Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications
- (2022) Jie Fang et al. Frontiers in Cellular and Infection Microbiology
- Lactobacillus reuteri MJM60668 Prevent Progression of Non-Alcoholic Fatty Liver Disease through Anti-Adipogenesis and Anti-Inflammatory Pathway
- (2022) Pia Werlinger et al. Microorganisms
- Effectiveness of Fecal Microbiota Transplantation for Weight Loss in Patients With Obesity Undergoing Bariatric Surgery
- (2022) Perttu Lahtinen et al. JAMA Network Open
- Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH
- (2022) Gideon G. Kang et al. iScience
- Pros and Cons: Is Fecal Microbiota Transplantation a safe and efficient treatment option for gutdysbiosis?
- (2021) Tom Marrs et al. ALLERGY
- Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis
- (2021) Fuxi Li et al. Lipids in Health and Disease
- NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
- (2021) Marinko Marušić et al. Canadian Journal of Gastroenterology and Hepatology
- A randomised placebo controlled trial of VSL#3® probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease
- (2021) Pui Lin Chong et al. BMC GASTROENTEROLOGY
- Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis
- (2021) Jian Fang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
- (2021) Soo Lim et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The role of microbiota and enteroendocrine cells in maintaining homeostasis in the human digestive tract
- (2021) Dagmara Woźniak et al. Advances in Medical Sciences
- Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities
- (2021) Richard Radun et al. SEMINARS IN LIVER DISEASE
- Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia
- (2021) Xiaokang Jia et al. Frontiers in Cellular and Infection Microbiology
- Role of Goblet Cells in Intestinal Barrier and Mucosal Immunity
- (2021) Songwei Yang et al. Journal of Inflammation Research
- Diet and gut microbiome in fatty liver and its associated liver cancer
- (2021) Yasi Pan et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Intestinal Barrier in Human Health and Disease
- (2021) Natalia Di Tommaso et al. International Journal of Environmental Research and Public Health
- E-Cadherin: An Important Functional Molecule at Respiratory Barrier Between Defence and Dysfunction
- (2021) Hasan Yuksel et al. Frontiers in Physiology
- TEX10 Promotes the Tumorigenesis and Radiotherapy Resistance of Urinary Bladder Carcinoma by Stabilizing XRCC6
- (2021) Sheng Luo et al. Journal of Immunology Research
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review
- (2021) Paulina Głuszyńska et al. Journal of Clinical Medicine
- The Synbiotic Combination of Akkermansia muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation
- (2021) María Juárez-Fernández et al. Antioxidants
- Physiological Role of Bile Acids Modified by the Gut Microbiome
- (2021) Yoshimitsu Kiriyama et al. Microorganisms
- Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
- (2021) Mohammad Shafi Kuchay et al. Biomedicines
- Akkermansia muciniphila Prevents Fatty Liver, Decreases Serum Triglycerides, and Maintains Gut Homeostasis
- (2020) Sejeong Kim et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Synbiotic Alters Fecal Microbiomes, but not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Non-alcoholic Fatty Liver Disease
- (2020) Eleonora Scorletti et al. GASTROENTEROLOGY
- Function of Akkermansia muciniphila in Obesity: Interactions With Lipid Metabolism, Immune Response and Gut Systems
- (2020) Yu Xu et al. Frontiers in Microbiology
- Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis
- (2020) Diletta Overi et al. Cells
- Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability
- (2020) Laura Craven et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Interaction between microbiota and immunity in health and disease
- (2020) Danping Zheng et al. CELL RESEARCH
- Lactococcus Lactis subsp. cremoris Elicits Protection Against Metabolic Changes Induced by a Western-style Diet
- (2020) Crystal R. Naudin et al. GASTROENTEROLOGY
- Randomised Double-Blind Placebo-Controlled Trial of Inulin with Metronidazole in Non-Alcoholic Fatty Liver Disease (NAFLD)
- (2020) Clara Yieh Lin Chong et al. Nutrients
- Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease
- (2020) Yan Yan et al. AMB Express
- Lactobacillus casei YRL577 ameliorates markers of non-alcoholic fatty liver and alters expression of genes within the intestinal bile acid pathway
- (2020) Zhe Zhang et al. BRITISH JOURNAL OF NUTRITION
- The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases
- (2020) Natalia Arias et al. Nutrients
- Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
- (2020) Xiaofan Jiang et al. Frontiers in Medicine
- Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
- (2020) Theresa J. Hydes et al. Clinical and Molecular Hepatology
- Mucus barrier, mucins and gut microbiota: the expected slimy partners?
- (2020) Paola Paone et al. GUT
- Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: A randomized clinical trial
- (2020) Vahideh Behrouz et al. JOURNAL OF FOOD SCIENCE
- Rhubarb Supplementation Prevents Diet-Induced Obesity and Diabetes in Association with Increased Akkermansia muciniphila in Mice
- (2020) Marion Régnier et al. Nutrients
- Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update
- (2020) Pufang Tan et al. Frontiers in Pharmacology
- Bile Acids and FXR: Novel Targets for Liver Diseases
- (2020) Mary Stofan et al. Frontiers in Medicine
- Immunological mechanisms and therapeutic targets of fatty liver diseases
- (2020) Hua Wang et al. Cellular & Molecular Immunology
- Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
- (2020) Romina Lomonaco et al. DIABETES CARE
- Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders
- (2020) Rajan Singh et al. Journal of Neurogastroenterology and Motility
- Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice
- (2019) Clea Bárcena et al. NATURE MEDICINE
- Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease
- (2019) Sang Bong Ahn et al. Scientific Reports
- Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health
- (2019) Kaitlyn Oliphant et al. Microbiome
- Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Ceramides
- (2019) Varman T. Samuel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dietary lipids, gut microbiota and lipid metabolism
- (2019) Marc Schoeler et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Minor Effect of Antibiotic Pre-treatment on the Engraftment of Donor Microbiota in Fecal Transplantation in Mice
- (2019) Tobias L. Freitag et al. Frontiers in Microbiology
- Gut microbiota in non‐alcoholic fatty liver disease and alcohol‐related liver disease: Current concepts and perspectives
- (2019) Juan P. Arab et al. HEPATOLOGY RESEARCH
- The Role of the Gut Microbiota in Lipid and Lipoprotein Metabolism
- (2019) Yijing Yu et al. Journal of Clinical Medicine
- Human gut microbiome: hopes, threats and promises
- (2018) Patrice D Cani GUT
- A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial
- (2018) Journal of Gastrointestinal and Liver Diseases
- Daily Consumption of Synbiotic Yogurt Decreases Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
- (2018) Farnush Bakhshimoghaddam et al. JOURNAL OF NUTRITION
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Fecal microbiota transplantation reverses antibiotic and chemotherapy-induced gut dysbiosis in mice
- (2018) Quentin Le Bastard et al. Scientific Reports
- The role of the microbiome in NAFLD and NASH
- (2018) Aleksandra A Kolodziejczyk et al. EMBO Molecular Medicine
- Probiotic supplements might not be universally-effective and safe: A review
- (2018) Damini Kothari et al. BIOMEDICINE & PHARMACOTHERAPY
- Interplay between tight junctions & adherens junctions
- (2017) Hannah K. Campbell et al. EXPERIMENTAL CELL RESEARCH
- Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
- (2017) Anna M. Diehl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease
- (2017) Aaron Buckley et al. Cold Spring Harbor Perspectives in Biology
- Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
- (2017) et al. Nutrients
- Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus
- (2017) Muhammad U. Sohail et al. Journal of Diabetes Research
- Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota
- (2017) Da Zhou et al. Scientific Reports
- Interaction of gut microbiota with bile acid metabolism and its influence on disease states
- (2016) Christopher Staley et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice
- (2016) Hubert Plovier et al. NATURE MEDICINE
- NAFLD and diabetes mellitus
- (2016) Herbert Tilg et al. Nature Reviews Gastroenterology & Hepatology
- Probiotics, prebiotics and synbiotics- a review
- (2015) Kavita. R. Pandey et al. JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE
- Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients
- (2014) Colleen R Kelly et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Lactobacillus rhamnosus GG Protects against Non-Alcoholic Fatty Liver Disease in Mice
- (2014) Yvonne Ritze et al. PLoS One
- Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study
- (2014) Juanwen Zhang et al. Scientific Reports
- Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats
- (2013) Shinya Fukunishi et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
- (2012) Anne Vrieze et al. GASTROENTEROLOGY
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
- (2012) Jorge Henao-Mejia et al. NATURE
- The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings
- (2011) A Mallat et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nutrition and physical activity in NAFLD: An overview of the epidemiological evidence
- (2011) Shira Zelber-Sagi WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation